Interventional Oncology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Embolization Devices, Ablation Devices, Support Devices), By Procedure (Thermal Tumour Ablation, Non-thermal Tumour Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Transcatheter Arterial Embolization (TAE)), By Cancer Type (Liver, Kidney, Lung, Bone, Others), By Region and Competition, 2020-2030F

November 2025 | 185 pages | ID: I4D96C916811EN
TechSci Research

Abstracts

The Global Interventional Oncology Devices Market, valued at USD 2.74 Billion in 2024, is projected to experience a CAGR of 7.90% to reach USD 4.32 Billion by 2030. Interventional oncology devices represent specialized medical instrumentation employed in image-guided, minimally invasive procedures for the diagnosis, treatment, and palliation of various cancers. The market's expansion is fundamentally driven by the increasing global prevalence of cancer and a growing preference for less invasive therapeutic interventions, which offer advantages such as reduced recovery times and fewer complications.

Key Market Drivers

The increasing global cancer incidence is a significant catalyst for the interventional oncology devices market, generating an expanding patient demographic in need of advanced diagnostic and treatment modalities. The rising number of new cancer diagnoses globally creates a fundamental demand for minimally invasive, image-guided interventions that offer targeted therapy with reduced systemic impact. For example, according to the 'Global Cancer Statistics, 2024' report published by the American Cancer Society and the International Agency for Research on Cancer on April 4, 2024, lung cancer was the most frequently diagnosed cancer in 2022, accounting for 2.5 million new cases worldwide, underscoring the substantial and ongoing demand for specialized oncology solutions. This growing burden necessitates a wider array of effective and less invasive tools, directly stimulating the development and adoption of interventional oncology devices.

Key Market Challenges

A notable challenge impeding market expansion is the limited availability of adequately trained interventional oncologists. These specialized medical procedures necessitate a high degree of expertise in image-guided, minimally invasive techniques, making the presence of skilled professionals critical for the adoption and utilization of associated devices. A deficiency in this expert workforce directly restricts the number of procedures that can be performed, thereby hampering the overall demand for interventional oncology instruments.

This scarcity limits patient access to advanced therapeutic interventions and constrains the market's growth potential.

Key Market Trends

Artificial Intelligence and Machine Learning Integration for Precision marks a significant trend in the Global Interventional Oncology Devices Market by refining diagnostic accuracy and therapeutic targeting. The application of sophisticated algorithms allows for the analysis of complex patient data, including genomics and imaging, to guide more precise interventions. According to a EuroAIM/EuSoMII 2024 survey, nearly 48% of European Society of Radiology members are currently using AI systems in their clinical practice, indicating a notable adoption rate within a directly relevant medical specialty. This integration facilitates optimized treatment pathways and improved patient stratification.

Key Market Players

• Medtronic PLC
• Terumo Corporation
• Boston Scientific Corporation
• Merit Medical Systems, Inc.
• HealthTronics, Inc.
• Johnson & Johnson
• Teleflex Inc.
• Angiodynamics Inc.
• MedWaves, Inc.
• Becton, Dickinson, and Company

Report Scope:

In this report, the Global Interventional Oncology Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Interventional Oncology Devices Market, By Product:
• Embolization Devices
• Ablation Devices
• Support Devices
• Interventional Oncology Devices Market, By Procedure:
• Thermal Tumor Ablation
• Non-thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization (TACE)
• Transcatheter Arterial Radioembolization (TARE)
• Transcatheter Arterial Embolization (TAE)
• Interventional Oncology Devices Market, By Cancer Type:
• Liver
• Kidney
• Lung
• Bone
• Others
• Interventional Oncology Devices Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Interventional Oncology Devices Market.

Available Customizations:

Global Interventional Oncology Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product (Embolization Devices, Ablation Devices, Support Devices)
  5.2.2. By Procedure (Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Transcatheter Arterial Embolization (TAE))
  5.2.3. By Cancer Type (Liver, Kidney, Lung, Bone, Others)
  5.2.4. By Region
  5.2.5. By Company (2024)
5.3. Market Map

6. NORTH AMERICA INTERVENTIONAL ONCOLOGY DEVICES MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product
  6.2.2. By Procedure
  6.2.3. By Cancer Type
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Interventional Oncology Devices Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Product
      6.3.1.2.2. By Procedure
      6.3.1.2.3. By Cancer Type
  6.3.2. Canada Interventional Oncology Devices Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Product
      6.3.2.2.2. By Procedure
      6.3.2.2.3. By Cancer Type
  6.3.3. Mexico Interventional Oncology Devices Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Product
      6.3.3.2.2. By Procedure
      6.3.3.2.3. By Cancer Type

7. EUROPE INTERVENTIONAL ONCOLOGY DEVICES MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Procedure
  7.2.3. By Cancer Type
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Interventional Oncology Devices Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Procedure
      7.3.1.2.3. By Cancer Type
  7.3.2. France Interventional Oncology Devices Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By Procedure
      7.3.2.2.3. By Cancer Type
  7.3.3. United Kingdom Interventional Oncology Devices Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By Procedure
      7.3.3.2.3. By Cancer Type
  7.3.4. Italy Interventional Oncology Devices Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Product
      7.3.4.2.2. By Procedure
      7.3.4.2.3. By Cancer Type
  7.3.5. Spain Interventional Oncology Devices Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Product
      7.3.5.2.2. By Procedure
      7.3.5.2.3. By Cancer Type

8. ASIA PACIFIC INTERVENTIONAL ONCOLOGY DEVICES MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By Procedure
  8.2.3. By Cancer Type
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Interventional Oncology Devices Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product
      8.3.1.2.2. By Procedure
      8.3.1.2.3. By Cancer Type
  8.3.2. India Interventional Oncology Devices Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product
      8.3.2.2.2. By Procedure
      8.3.2.2.3. By Cancer Type
  8.3.3. Japan Interventional Oncology Devices Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product
      8.3.3.2.2. By Procedure
      8.3.3.2.3. By Cancer Type
  8.3.4. South Korea Interventional Oncology Devices Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product
      8.3.4.2.2. By Procedure
      8.3.4.2.3. By Cancer Type
  8.3.5. Australia Interventional Oncology Devices Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product
      8.3.5.2.2. By Procedure
      8.3.5.2.3. By Cancer Type

9. MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY DEVICES MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By Procedure
  9.2.3. By Cancer Type
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Interventional Oncology Devices Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product
      9.3.1.2.2. By Procedure
      9.3.1.2.3. By Cancer Type
  9.3.2. UAE Interventional Oncology Devices Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product
      9.3.2.2.2. By Procedure
      9.3.2.2.3. By Cancer Type
  9.3.3. South Africa Interventional Oncology Devices Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product
      9.3.3.2.2. By Procedure
      9.3.3.2.3. By Cancer Type

10. SOUTH AMERICA INTERVENTIONAL ONCOLOGY DEVICES MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Product
  10.2.2. By Procedure
  10.2.3. By Cancer Type
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Interventional Oncology Devices Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product
      10.3.1.2.2. By Procedure
      10.3.1.2.3. By Cancer Type
  10.3.2. Colombia Interventional Oncology Devices Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product
      10.3.2.2.2. By Procedure
      10.3.2.2.3. By Cancer Type
  10.3.3. Argentina Interventional Oncology Devices Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product
      10.3.3.2.2. By Procedure
      10.3.3.2.3. By Cancer Type

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Medtronic PLC
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Terumo Corporation
15.3. Boston Scientific Corporation
15.4. Merit Medical Systems, Inc.
15.5. HealthTronics, Inc.
15.6. Johnson & Johnson
15.7. Teleflex Inc.
15.8. Angiodynamics Inc.
15.9. MedWaves, Inc.
15.10. Becton, Dickinson, and Company

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER